Zymeworks is attending and presenting at the AACR Oncology Industry Partnering Event: From Cancer Discoveries to Patients taking place April 24-25 in Chicago, IL.

“We’re excited to participate in this year’s AACR Oncology Industry Partnering Event,” said Lucas Donigian, Vice President, Business and Commercial Development. “This event provides a critical platform for pharmaceutical and biotechnology companies to collaborate, share innovative drug development strategies, and explore potential partnerships that can accelerate cancer research.”

On April 24, senior leadership will participate in a panel session “T cell Engagers” at 5:45 pm Central Time (CT) and present during the Showcase Session at 4:30 pm CT.

Partnerships are central to Zymeworks’ corporate strategy, enabling the company to expand and accelerate its efforts to bring novel multifunctional therapeutics to the broadest group of patients in the most efficient manner possible.

Learn more about our active partnerships and partnering focus here.